Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Mineralys Therapeutics Inc., 3 years.
Mineralys Therapeutics Inc.
Director
Werewolf Therapeutics Inc.
Director
Acrivon Therapeutics Inc.
Director
Evommune Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acrivon Therapeutics Inc. June 13, 202592.1%
-
Mineralys Therapeutics Inc. May 22, 202585.6%
-
Werewolf Therapeutics Inc. June 21, 202378.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Acrivon Therapeutics Inc. | Grant or award | +9,366 | — | — |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Grant or award | +6,200 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.